Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

NASDAQ:OLPX - Nasdaq - US6793691089 - Common Stock - Currency: USD

1.4  -0.1 (-6.67%)

After market: 1.38 -0.02 (-1.43%)

Fundamental Rating

5

Overall OLPX gets a fundamental rating of 5 out of 10. We evaluated OLPX against 35 industry peers in the Personal Care Products industry. OLPX has an average financial health and profitability rating. OLPX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year OLPX was profitable.
In the past year OLPX had a positive cash flow from operations.
In the past 5 years OLPX has always been profitable.
Each year in the past 5 years OLPX had a positive operating cash flow.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With a Return On Assets value of 0.69%, OLPX perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.39%, OLPX is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.86%, OLPX is in line with its industry, outperforming 45.71% of the companies in the same industry.
OLPX had an Average Return On Invested Capital over the past 3 years of 8.40%. This is significantly below the industry average of 15.14%.
The 3 year average ROIC (8.40%) for OLPX is well above the current ROIC(2.86%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.69%
ROE 1.39%
ROIC 2.86%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 100 200 300 400

1.3 Margins

OLPX has a Profit Margin (2.91%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of OLPX has declined.
OLPX has a Operating Margin of 15.16%. This is in the better half of the industry: OLPX outperforms 77.14% of its industry peers.
In the last couple of years the Operating Margin of OLPX has declined.
OLPX has a Gross Margin of 70.42%. This is in the better half of the industry: OLPX outperforms 65.71% of its industry peers.
In the last couple of years the Gross Margin of OLPX has declined.
Industry RankSector Rank
OM 15.16%
PM (TTM) 2.91%
GM 70.42%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

OLPX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for OLPX has been increased compared to 1 year ago.
OLPX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OLPX has been reduced compared to a year ago.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

OLPX has an Altman-Z score of 1.85. This is not the best score and indicates that OLPX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of OLPX (1.85) is worse than 60.00% of its industry peers.
The Debt to FCF ratio of OLPX is 7.08, which is on the high side as it means it would take OLPX, 7.08 years of fcf income to pay off all of its debts.
OLPX has a Debt to FCF ratio of 7.08. This is in the better half of the industry: OLPX outperforms 62.86% of its industry peers.
OLPX has a Debt/Equity ratio of 0.73. This is a neutral value indicating OLPX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.73, OLPX is doing worse than 65.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.08
Altman-Z 1.85
ROIC/WACC0.31
WACC9.17%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 10.74. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX has a better Current ratio (10.74) than 100.00% of its industry peers.
A Quick Ratio of 9.53 indicates that OLPX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 9.53, OLPX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.74
Quick Ratio 9.53
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The earnings per share for OLPX have decreased strongly by -42.86% in the last year.
The earnings per share for OLPX have been decreasing by -20.10% on average. This is quite bad
OLPX shows a decrease in Revenue. In the last year, the revenue decreased by -5.11%.
OLPX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.32% yearly.
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-100%
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%-1.95%

3.2 Future

The Earnings Per Share is expected to decrease by -5.85% on average over the next years.
The Revenue is expected to grow by 29.95% on average over the next years. This is a very strong growth
EPS Next Y-39.21%
EPS Next 2Y-13.2%
EPS Next 3Y-5.85%
EPS Next 5YN/A
Revenue Next Year2.36%
Revenue Next 2Y2.74%
Revenue Next 3Y3.32%
Revenue Next 5Y29.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.50 indicates a rather expensive valuation of OLPX.
OLPX's Price/Earnings ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 74.29% of the companies in the same industry.
OLPX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.15.
The Price/Forward Earnings ratio is 16.89, which indicates a correct valuation of OLPX.
OLPX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 65.71% of the companies in the same industry.
OLPX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.5
Fwd PE 16.89
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

OLPX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. OLPX is cheaper than 74.29% of the companies in the same industry.
OLPX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OLPX is cheaper than 91.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.17
EV/EBITDA 8.55
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as OLPX's earnings are expected to decrease with -5.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.2%
EPS Next 3Y-5.85%

0

5. Dividend

5.1 Amount

No dividends for OLPX!.
Industry RankSector Rank
Dividend Yield N/A

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (6/30/2025, 8:00:02 PM)

After market: 1.38 -0.02 (-1.43%)

1.4

-0.1 (-6.67%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners13.95%
Inst Owner Change-0.07%
Ins Owners0.5%
Ins Owner Change34.04%
Market Cap932.29M
Analysts51.43
Price Target2.11 (50.71%)
Short Float %6.97%
Short Ratio7.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.48%
Min EPS beat(2)-100%
Max EPS beat(2)69.03%
EPS beat(4)1
Avg EPS beat(4)-10.57%
Min EPS beat(4)-100%
Max EPS beat(4)69.03%
EPS beat(8)4
Avg EPS beat(8)-4.95%
EPS beat(12)8
Avg EPS beat(12)-0.02%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.87%
Min Revenue beat(2)1.35%
Max Revenue beat(2)12.38%
Revenue beat(4)2
Avg Revenue beat(4)1.15%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)12.38%
Revenue beat(8)5
Avg Revenue beat(8)-0.82%
Revenue beat(12)7
Avg Revenue beat(12)-1.02%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.52%
PT rev (3m)1.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.37%
EPS NY rev (1m)3.52%
EPS NY rev (3m)-4.83%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-0.29%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)4.63%
Valuation
Industry RankSector Rank
PE 17.5
Fwd PE 16.89
P/S 2.22
P/FCF 10.17
P/OCF 9.67
P/B 1.06
P/tB N/A
EV/EBITDA 8.55
EPS(TTM)0.08
EY5.71%
EPS(NY)0.08
Fwd EY5.92%
FCF(TTM)0.14
FCFY9.83%
OCF(TTM)0.14
OCFY10.34%
SpS0.63
BVpS1.32
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 1.39%
ROCE 3.74%
ROIC 2.86%
ROICexc 4.33%
ROICexgc 70.3%
OM 15.16%
PM (TTM) 2.91%
GM 70.42%
FCFM 21.78%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
ROICexc(3y)11%
ROICexc(5y)12.02%
ROICexgc(3y)125.03%
ROICexgc(5y)244.84%
ROCE(3y)11%
ROCE(5y)12.99%
ROICexcg growth 3Y-27.54%
ROICexcg growth 5Y-25.57%
ROICexc growth 3Y-37.52%
ROICexc growth 5Y-59.98%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 7.08
Debt/EBITDA 5.49
Cap/Depr 9.02%
Cap/Sales 1.14%
Interest Coverage 1.1
Cash Conversion 82.4%
Profit Quality 748.64%
Current Ratio 10.74
Quick Ratio 9.53
Altman-Z 1.85
F-Score6
WACC9.17%
ROIC/WACC0.31
Cap/Depr(3y)7.27%
Cap/Depr(5y)5.1%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.53%
Profit Quality(3y)364.56%
Profit Quality(5y)302.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-100%
EPS Next Y-39.21%
EPS Next 2Y-13.2%
EPS Next 3Y-5.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.11%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%-1.95%
Revenue Next Year2.36%
Revenue Next 2Y2.74%
Revenue Next 3Y3.32%
Revenue Next 5Y29.95%
EBIT growth 1Y-31.54%
EBIT growth 3Y-40.62%
EBIT growth 5Y-5.47%
EBIT Next Year-16.39%
EBIT Next 3Y-2.83%
EBIT Next 5YN/A
FCF growth 1Y-59.91%
FCF growth 3Y-11.33%
FCF growth 5Y21.31%
OCF growth 1Y-58.32%
OCF growth 3Y-10.57%
OCF growth 5Y22.16%